645651305	645651305	CD	B-NP	O
|	|	NN	I-NP	O
GPMHC	GPMHC	NN	I-NP	O
|	|	NN	I-NP	O
83348256	83348256	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
180252	180252	CD	B-NP	O
|	|	CC	I-NP	O
10/4/2002	10/4/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CELLULITIS	CELLULITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2002	11/13/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/11/2002	6/11/2002	CD	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
LOWER	LOWER	NN	B-NP	O
EXTREMITY	EXTREMITY	NN	I-NP	O
VENOUS	VENOUS	NNP	I-NP	O
STASIS	STASIS	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
SUPERIMPOSED	SUPERIMPOSED	NNP	I-NP	O
CELLULITIS	CELLULITIS	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
LOWER	LOWER	NN	B-NP	O
EXTREMITY	EXTREMITY	NN	I-NP	O
VENOUS	VENOUS	NNP	I-NP	O
STASIS	STASIS	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
SUPERIMPOSED	SUPERIMPOSED	NNP	I-NP	O
CELLULITIS	CELLULITIS	NNP	I-NP	O
,	,	,	O	O
RESOLVED	RESOLVED	NNP	B-NP	O
.	.	.	O	O

SERVICE	SERVICE	NN	B-NP	O
:	:	:	O	O
GENERAL	GENERAL	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
Copeo	Copeo	NNP	I-NP	O
CONSULTS	CONSULTS	NNP	I-NP	O
OBTAINED	OBTAINED	VBD	B-VP	O
:	:	:	O	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
and	and	CC	I-NP	O
Dermatology	Dermatology	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56	56	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
Psychiatric	Psychiatric	JJ	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
visits	visit	NNS	B-NP	O
to	to	TO	B-PP	O
multiple	multiple	JJ	B-NP	O
care	care	NN	I-NP	O
providers	provider	NNS	I-NP	O
,	,	,	O	O
readmitted	readmitte	VBN	B-VP	O
for	for	IN	B-PP	O
painful	painful	JJ	B-NP	O
,	,	,	I-NP	O
swollen	swollen	JJ	I-NP	O
,	,	,	I-NP	O
red	red	JJ	I-NP	O
,	,	,	I-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
2002	2002	CD	B-NP	O
treated	treat	VBN	B-VP	O
at	at	IN	B-PP	O
Istspauld	Istspauld	NNP	B-NP	O
Health	Health	NNP	I-NP	O
with	with	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
clostridium	clostridium	NN	I-NP	O
difficile	difficile	NN	I-NP	O
colitis	colitis	NN	I-NP	O
;	;	:	O	O
previous	previous	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
entirely	entirely	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
now	now	RB	B-VP	O
returned	return	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
positive	positive	JJ	B-NP	O
subjective	subjective	JJ	I-NP	O
fevers	fever	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chills	chill	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
is	be	VBZ	B-VP	O
98.2	98.2	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
87	87	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
134/69	134/69	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20/minute	20/minute	VBP	B-VP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
middle	middle	JJ	I-NP	O
aged	aged	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
pressured	pressured	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
tangential	tangential	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
brawny	brawny	JJ	B-NP	O
hyperpigmentation	hyperpigmentation	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
erythematous	erythematous	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
shiny	shiny	JJ	I-ADJP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
tender	tender	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
touch	touch	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
8.6	8.6	CD	I-NP	O
,	,	,	O	O
urinalysis	urinalysis	NN	B-NP	O
4	4	CD	I-NP	O
+	+	SYM	B-ADJP	O
squamous	squamous	JJ	I-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
bony	bony	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
From	From	IN	B-PP	O
an	an	DT	B-NP	O
I.D.	I.D.	NNP	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Ancef	Ancef	NN	B-NP	O
without	without	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
input	input	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
intravenous	intravenous	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	B-cell_line
Blood	Blood	NNP	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
from	from	IN	B-PP	O
February	February	NNP	B-NP	O
A	A	NNP	I-NP	O
repeat	repeat	NN	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
dermatology	dermatology	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
and	and	CC	O	O
gave	give	VBD	B-VP	O
an	an	DT	B-NP	O
impression	impression	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
venous	venous	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
tinea	tinea	NN	I-NP	O
pedis	pedis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
consult	consult	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
discontinuing	discontinue	VBG	I-VP	O
nystatin	nystatin	NN	B-NP	O
and	and	CC	I-NP	O
triamcinolone	triamcinolone	NN	I-NP	O
with	with	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
Spectazole	Spectazole	NN	B-NP	O
and	and	CC	I-NP	O
miconazole	miconazole	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
toes	toe	NNS	I-NP	O
on	on	IN	B-PP	O
lower	low	JJR	B-NP	O
legs	leg	NNS	I-NP	O
and	and	CC	O	O
inframammary	inframammary	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
On	On	IN	B-PP	O
October	October	NNP	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
impression	impression	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
voiced	voice	VBD	B-VP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
properly	properly	RB	I-VP	O
cover	cover	VB	I-VP	O
non	non	JJ	B-NP	O
staphylococcal	staphylococcal	JJ	I-NP	O
etiologies	etiology	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
gram	gram	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
to	to	TO	B-VP	O
q.	q.	VB	I-VP	O
eight	eight	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
4	4	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
was	be	VBD	B-VP	O
draining	drain	VBG	I-VP	O
a	a	DT	B-NP	O
serous	serous	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
fluid	fluid	JJ	I-NP	O
collections	collection	NNS	I-NP	O
.	.	.	O	O

Debridement	Debridement	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
recommended	recommend	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
receiving	receive	VBG	I-VP	O
levaquin	levaquin	NN	B-NP	O
.	.	.	O	O

Dermatology	Dermatology	NN	B-NP	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
once	once	RB	B-ADVP	O
more	more	JJR	I-ADVP	O
and	and	CC	O	O
supported	support	VBD	B-VP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
hematologic	hematologic	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
noninvasive	noninvasive	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
psychiatric	psychiatric	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
undifferentiated	undifferentiated	JJ	I-NP	O
psychiatric	psychiatric	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADJP	O
possibly	possibly	RB	I-ADJP	O
bipolar	bipolar	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
manic	manic	JJ	I-NP	O
component	component	NN	I-NP	O
but	but	CC	O	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
Psych	Psych	NN	B-NP	O
and	and	CC	O	O
instead	instead	RB	B-VP	O
insisted	insist	VBN	I-VP	O
on	on	IN	B-PP	O
taking	take	VBG	B-VP	O
Dexedrine	Dexedrine	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
claimed	claim	VBN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
narcolepsy	narcolepsy	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
prescription	prescription	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reportedly	reportedly	RB	B-ADVP	O
took	take	VBD	B-VP	O
her	her	PRP	B-NP	O
own	own	JJ	I-NP	O
medications	medication	NNS	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
pressured	pressured	JJ	B-NP	O
speech	speech	NN	I-NP	O
,	,	,	O	O
tangential	tangential	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
short-term	short-term	JJ	I-NP	O
memory	memory	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lacks	lack	VBZ	B-VP	O
any	any	DT	B-NP	O
suicidal	suicidal	JJ	I-NP	O
or	or	CC	I-NP	O
homicidal	homicidal	JJ	I-NP	O
ideation	ideation	NN	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
psychotic	psychotic	JJ	I-NP	O
component	component	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
and	and	CC	I-NP	O
fluid	fluid	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
involved	involve	VBN	I-NP	O
sources	source	NNS	I-NP	O
believed	believe	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
fundamental	fundamental	JJ	I-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
was	be	VBD	B-VP	O
fluid	fluid	JJ	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
venous	venous	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
ultimately	ultimately	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
showed	show	VBD	B-VP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
dilatation	dilatation	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
compromise	compromise	NN	I-NP	O
in	in	IN	B-PP	O
function	function	NN	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
suffer	suffer	VB	I-VP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
while	while	IN	B-SBAR	O
standing	stand	VBG	B-VP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
She	She	NNP	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
head	head	NN	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
without	without	IN	B-PP	O
functional	functional	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
instability	instability	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
later	later	RB	B-VP	O
complained	complain	VBN	I-VP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
complained	complain	VBD	B-VP	O
resulted	result	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-NP	O
three	three	CD	I-NP	O
views	view	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
foot	foot	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
fracture	fracture	NN	B-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
issue	issue	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
was	be	VBD	B-VP	O
her	her	PRP$	B-NP	O
refusal	refusal	NN	I-NP	O
to	to	TO	B-VP	O
look	look	VB	I-VP	O
forward	forward	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
despite	despite	IN	B-PP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
had	have	VBD	B-VP	O
corrected	correct	VBN	I-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
underlying	underlying	JJ	I-NP	O
condition	condition	NN	I-NP	O
would	would	MD	B-VP	O
require	require	VB	I-VP	O
comprehensive	comprehensive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
and	and	CC	I-NP	O
outpatient	outpatient	NN	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
29	29	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
reconsult	reconsult	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
only	only	RB	B-NP	O
stasis	stasis	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
continued	continue	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
September	September	NNP	B-NP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
ready	ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
with	with	IN	B-PP	O
potassium	potassium	NN	B-NP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
meq	meq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
to	to	TO	B-VP	O
replace	replace	VB	I-VP	O
any	any	DT	B-NP	O
losses	loss	NNS	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
meds	med	NNS	I-NP	O
were	be	VBD	B-VP	O
prescribed	prescribe	VBN	I-VP	O
as	as	IN	B-PP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
ketoconazole	ketoconazole	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
supply	supply	NN	I-NP	O
of	of	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
her	her	PRP$	B-NP	B-cell_type
pain	pain	NN	I-NP	I-cell_type
until	until	IN	B-SBAR	I-cell_type
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
wit	wit	VB	I-VP	O
her	her	PRP$	B-NP	O
new	new	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
provider	provider	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Law	Law	NNP	I-NP	O
at	at	IN	B-PP	O
Ganco	Ganco	NNP	B-NP	O
Wo	Wo	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
leave	leave	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
problems	problem	NNS	I-NP	O
with	with	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
which	which	WDT	B-NP	O
predates	predate	VBZ	B-VP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
plans	plan	VBZ	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
Urogynecologist	Urogynecologist	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Mihalko	Mihalko	NNP	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
arranged	arrange	VBD	B-VP	O
outpatient	outpatient	NN	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointments	appointment	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
doctors	doctor	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Stechlinski	Stechlinski	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Mccarter	Mccarter	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
All	All	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
information	information	NN	I-NP	O
was	be	VBD	B-VP	O
communicated	communicate	VBN	I-VP	O
verbally	verbally	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
emphasized	emphasize	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
's	'	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
elevate	elevate	VB	I-VP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
regularly	regularly	RB	B-ADVP	O
and	and	CC	O	O
to	to	TO	B-VP	O
try	try	VB	I-VP	O
to	to	TO	I-VP	O
limit	limit	VB	I-VP	O
soft	soft	JJ	B-NP	O
drink	drink	NN	I-NP	O
intake	intake	NN	I-NP	O
as	as	IN	B-PP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	I-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
swelling	swelling	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
weight	weight	VB	I-VP	O
herself	herself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
steadily	steadily	RB	I-VP	O
increasing	increase	VBG	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
advised	advise	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
for	for	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
redness	redness	NN	I-NP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
pronounced	pronounced	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
any	any	DT	B-NP	O
numbness	numbness	NN	I-NP	O
or	or	CC	I-NP	O
tingling	tingling	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
skin	skin	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Betoptic	Betoptic	JJ	B-NP	O
S	S	NN	I-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
0.25	0.25	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Klonopin	Klonopin	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
60	60	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	I-NP	O
ipratropium	ipratropium	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
inhaler	inhaler	IN	B-PP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
4-6h	4-6h	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
WILLIE	WILLIE	NNP	B-NP	O
BUSTER	BUSTER	NNP	I-NP	O
PUSKAR	PUSKAR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SW597	SW597	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
COLIN	COLIN	NNP	B-NP	O
THODY	THODY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OM94	OM94	NNP	I-NP	O
QN041/443660	QN041/443660	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
84171	84171	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

R2DE10M8E4	R2DE10M8E4	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
2/5/02	2/5/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/18/02	10/18/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Oakey	Oakey	NNP	I-NP	O
,	,	,	O	O
Ton	Ton	NNP	B-NP	O
Of	Of	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O

